CD8A and neoplasm: These cells are found in the patient’s tumor microenvironment and lymphoid organs due to their ability to suppress innate and adaptive antitumoral immunity (inhibit CD4+ and CD8+ T cells, and block dendritic cell maturation) [61,62].